In PCa, methylation of PYCARD has also been demonstrated in several tumor cell lines, including LNCaP, LAPC-4, MDAPCa2b, DU145, and PC-3 [114, 115], but not in the benign prostate epithelial cell line BPH-1, or normal prostate epithelial cells. Here, PYCARD is linked to neoplasm.